Lantheus Holdings Inc.

(LNTH) Trade

By |

Profile

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in diagnostic procedures, such as cardiac ultrasounds, or echocardiograms, x-ray imaging used by physicians to progress the clarity of the diagnostic image. The company's portfolio of imaging products includes medical radiopharmaceuticals such as DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, and Neurolite. Its revenue is generated from the sales of diagnostic imaging agents to wholesalers, distributors radiopharmacy and directly to hospitals and clinics predominantly in the United States.

Contact Information

Website: www.lantheus.com
Email: ir@lantheus.com
Main Phone: +1 978 671-8001
Address: 331 Treble Cove Road
State: MA
City / Town: North Billerica
Country: USA
Postal Code: 01862

Issuer Information

Exchange: NSD
CEO: Mary Anne Heino
Employees: 508
NAICS: Medical Laboratories(621511)

Equities News

Profile

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in diagnostic procedures, such as cardiac ultrasounds, or echocardiograms, x-ray imaging used by physicians to progress the clarity of the diagnostic image. The company's portfolio of imaging products includes medical radiopharmaceuticals such as DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, and Neurolite. Its revenue is generated from the sales of diagnostic imaging agents to wholesalers, distributors radiopharmacy and directly to hospitals and clinics predominantly in the United States.

Contact Information

Website: www.lantheus.com
Email: ir@lantheus.com
Main Phone: +1 978 671-8001
Address: 331 Treble Cove Road
State: MA
City / Town: North Billerica
Country: USA
Postal Code: 01862

Issuer Information

Exchange: NSD
CEO: Mary Anne Heino
Employees: 508
NAICS: Medical Laboratories(621511)

Equities News

$ 14.53 $ 0.32 (2.22%)
Last Price 14.53 Change $ 0.32 Change % 2.22 Tick N/A
Bid 14.00 Bid Size 500.00 Ask 18.40 Ask Size 300.00
Open 14.19 High 14.67 Low 13.91 Prev Close 14.21
Last Trade Volume 341,081 52 Wk Hi 29.80 52 Wk Low 8.68
Market Cap 580.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 39,940,964.00 EPS (TTM) 0.62 PE Ratio 22.90 Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 13 88
Number of Buys 2 22
Number of Sells 11 66
Net Activity -38894 -5870252
Last 10 Buys Shares
N/A 0
Last 10 Sell Shares
Cesare Orlandi 1,000
Cesare Orlandi 1,000
Cesare Orlandi 1,000
Cesare Orlandi 1,000
Cesare Orlandi 1,000
Cesare Orlandi 1,000
Michael P. Duffy 1,000
Michael P. Duffy 1,000
Timothy G. Healey 1,000
John W. Crowley 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 26 26 26 26
Low Target Price Estimate 21 21 21 21
Mean Target Price Estimate 23.5 23.5 23.5 23.5
Standard Deviation 3.54 3.54 3.54 3.54
Date of Most Recent Estimate 05/31/18 05/31/18 05/29/18 05/31/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1